CEACAM5 and colorectal carcinoma: 3.4. Discrimination of Cancer Stages and Advanced/Metastatic CRC by Combining the Biomarkers of the CD45neg EpCAMpos CTCs, CD45neg EpCAMneg Cell Count, and CEA Level